Sarah Kerrigan

2.1k total citations
68 papers, 1.3k citations indexed

About

Sarah Kerrigan is a scholar working on Toxicology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Sarah Kerrigan has authored 68 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Toxicology, 19 papers in Pharmacology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Sarah Kerrigan's work include Forensic Toxicology and Drug Analysis (35 papers), Alcohol Consumption and Health Effects (13 papers) and Psychedelics and Drug Studies (12 papers). Sarah Kerrigan is often cited by papers focused on Forensic Toxicology and Drug Analysis (35 papers), Alcohol Consumption and Health Effects (13 papers) and Psychedelics and Drug Studies (12 papers). Sarah Kerrigan collaborates with scholars based in United States, Canada and Sweden. Sarah Kerrigan's co-authors include Barry Levine, Barry K. Logan, William H. Phillips, Donald E. Brooks, Marilyn A. Huestis, Karen S. Scott, Amanda L A Mohr, Cameron Crandall, Patrick E. McKinney and A. Keith Miles and has published in prestigious journals such as Journal of Chromatography A, Clinical Chemistry and Journal of Immunological Methods.

In The Last Decade

Sarah Kerrigan

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Kerrigan United States 22 703 356 259 232 226 68 1.3k
Ritva Karinen Norway 22 900 1.3× 275 0.8× 242 0.9× 420 1.8× 245 1.1× 56 1.4k
Vigdis Vindenes Norway 23 898 1.3× 470 1.3× 235 0.9× 294 1.3× 167 0.7× 87 1.7k
Jérémy Carlier Italy 21 585 0.8× 585 1.6× 208 0.8× 166 0.7× 321 1.4× 67 1.3k
Emilia Marchei Italy 33 792 1.1× 612 1.7× 268 1.0× 282 1.2× 344 1.5× 95 2.4k
Shawn P. Vorce United States 18 595 0.8× 176 0.5× 323 1.2× 95 0.4× 139 0.6× 25 898
Manuela Pellegrini Italy 32 1.0k 1.4× 671 1.9× 330 1.3× 254 1.1× 393 1.7× 109 2.6k
Sarah M.R. Wille Belgium 27 947 1.3× 421 1.2× 227 0.9× 322 1.4× 341 1.5× 70 1.9k
Donna M Papsun United States 22 1.1k 1.5× 227 0.6× 315 1.2× 95 0.4× 253 1.1× 47 1.4k
Sebastian Dresen Germany 21 928 1.3× 451 1.3× 202 0.8× 582 2.5× 530 2.3× 22 1.8k
Jochen Beyer Australia 18 566 0.8× 286 0.8× 149 0.6× 170 0.7× 251 1.1× 39 1.2k

Countries citing papers authored by Sarah Kerrigan

Since Specialization
Citations

This map shows the geographic impact of Sarah Kerrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Kerrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Kerrigan more than expected).

Fields of papers citing papers by Sarah Kerrigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Kerrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Kerrigan. The network helps show where Sarah Kerrigan may publish in the future.

Co-authorship network of co-authors of Sarah Kerrigan

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Kerrigan. A scholar is included among the top collaborators of Sarah Kerrigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Kerrigan. Sarah Kerrigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohr, Amanda L A, et al.. (2025). North America laboratory survey data for drug testing in drug-impaired driving and traffic fatality investigations. Journal of Analytical Toxicology. 49(7). 436–441. 1 indexed citations
4.
Kerrigan, Sarah, et al.. (2024). Temperature and pH‐dependent stability of fentanyl analogs: Degradation pathways and potential biomarkers. Journal of Forensic Sciences. 69(5). 1799–1814. 2 indexed citations
5.
Norton, Anderson, Catherine Ulrich, & Sarah Kerrigan. (2023). Unit Transformation Graphs: Modeling Students’ Mathematics in Meeting the Cognitive Demands of Fractions Multiplication Tasks. Journal for Research in Mathematics Education. 54(4). 240–259. 6 indexed citations
6.
Kerrigan, Sarah, et al.. (2020). Identification of metabolites and potential biomarkers of kratom in urine. Journal of Chromatography A. 1 indexed citations
7.
Kerrigan, Sarah, et al.. (2018). Quantitative analysis of desomorphine in blood and urine using solid phase extraction and gas chromatography-mass spectrometry. Journal of Chromatography B. 1106-1107. 43–49. 5 indexed citations
8.
Kerrigan, Sarah, et al.. (2018). Identification of five Mitragyna alkaloids in urine using liquid chromatography-quadrupole/time of flight mass spectrometry. Journal of Chromatography B. 1080. 11–19. 27 indexed citations
9.
Haines, Donovan C., et al.. (2018). In vitro metabolism of desomorphine. Forensic Science International. 289. 140–149. 9 indexed citations
10.
Kerrigan, Sarah, et al.. (2018). Quantification of suvorexant in blood using liquid chromatography-quadrupole/time of flight (LC-Q/TOF) mass spectrometry. Journal of Chromatography B. 1091. 87–95. 10 indexed citations
11.
Rana, Sumandeep, et al.. (2018). Cathinone stability in authentic urine specimens. Forensic Science International. 286. 54–60. 12 indexed citations
12.
Kerrigan, Sarah, et al.. (2016). Identification of Suvorexant in Urine Using Liquid Chromatography-Quadrupole/Time-of-Flight Mass Spectrometry (LC-Q/TOF-MS). Journal of Analytical Toxicology. 41(3). 224–229. 13 indexed citations
13.
Kerrigan, Sarah, et al.. (2011). Evaluation of Commercial Enzyme-Linked Immunosorbent Assays to Identify Psychedelic Phenethylamines. Journal of Analytical Toxicology. 35(7). 444–451. 21 indexed citations
14.
Kerrigan, Sarah, et al.. (2011). Simultaneous Detection of Ten Psychedelic Phenethylamines in Urine by Gas Chromatography-Mass Spectrometry. Journal of Analytical Toxicology. 35(7). 459–469. 11 indexed citations
15.
Kerrigan, Sarah, et al.. (2010). Quantitative Analysis of Gamma‐Hydroxybutyrate at Endogenous Concentrations in Hair using Liquid Chromatography Tandem Mass Spectrometry. Journal of Forensic Sciences. 55(2). 531–537. 27 indexed citations
16.
Downey, D., et al.. (2009). Quantitative Analysis of Carisoprodol and Meprobamate in Whole Blood Using Benzylcarbamate and Deuterated Meprobamate as Internal Standards. Journal of Analytical Toxicology. 33(5). 278–282. 8 indexed citations
17.
Kerrigan, Sarah, et al.. (2009). Quantitative Determination of Caffeine and Alcohol in Energy Drinks and the Potential to Produce Positive Transdermal Alcohol Concentrations in Human Subjects. Journal of Analytical Toxicology. 33(1). 27–33. 25 indexed citations
18.
Kerrigan, Sarah, et al.. (2005). Distribution of GHB in Tissues and Fluids Following a Fatal Overdose. Journal of Analytical Toxicology. 29(5). 398–400. 37 indexed citations
19.
Kerrigan, Sarah, et al.. (2004). Postmortem Morphine Concentrations Following Use of a Continuous Infusion Pump. Journal of Analytical Toxicology. 28(6). 529–532. 10 indexed citations
20.
Kerrigan, Sarah. (2002). In Vitro Production of Gamma-Hydroxybutyrate in Antemortem Urine Samples. Journal of Analytical Toxicology. 26(8). 571–574. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026